UnitedHealth Group Inc.

UNH ·Financial, Insurance - Health, United States

UnitedHealth Group Incorporated (UNH)

Overview

UnitedHealth Group is the largest health care company in the United States and, by revenue, one of the largest companies in the world. Headquartered in Eden Prairie, Minnesota, it operates as a diversified health enterprise with two complementary arms: UnitedHealthcare, a health benefits (insurance) business, and Optum, a health services business spanning care delivery, data/analytics, and pharmacy benefits. The company employs roughly 390,000 people worldwide and generated $447.6 billion in revenue in fiscal year 2025, with net earnings of about $12.1 billion. UnitedHealthcare alone covers on the order of 46-50 million people, while Optum's various businesses touch well over 100 million consumers, making UNH one of the most systemically important companies in the U.S. health care system.

What They Do & How They Make Money

UnitedHealth Group's business rests on two pillars that are designed to work together. UnitedHealthcare is the traditional insurance side: it collects premiums from employers, individuals, and government programs (Medicare, Medicaid, and military/veterans' health plans) in exchange for managing members' health coverage and paying their medical claims. Revenue here is driven by premiums per member, and profitability depends on keeping the "medical care ratio" — the share of premium revenue paid out in claims — below what's collected, while also meeting regulatory minimums on how much premium must go toward actual care (the ACA's medical loss ratio rules).

Optum is the services and technology side, and it makes money in a fundamentally different way — through fees for services rendered rather than risk-based premiums, though it increasingly takes on capitated (fixed-fee, at-risk) arrangements for patient populations as well. Optum Health employs or affiliates with physicians and operates clinics, providing direct patient care, often paid on a value-based or capitated basis. Optum Insight sells data analytics, software, revenue-cycle management, and consulting services to hospitals, physician groups, and other payers. Optum Rx acts as a pharmacy benefit manager (PBM), negotiating drug prices and rebates with manufacturers on behalf of employers and health plans, operating mail-order and specialty pharmacies, and earning money on the spread between what it charges clients and pays pharmacies/manufacturers, plus administrative fees.

The strategic logic that ties the two together is vertical integration: UnitedHealthcare's massive membership base generates a river of premium dollars, a meaningful share of which flows to Optum's clinics, pharmacies, and data services — meaning the company can, in effect, capture margin on both the insurance and the care-delivery/servicing sides of the same patient encounter. This "flywheel" has been core to UNH's growth and profitability for over a decade, though it has also become the central focus of the antitrust scrutiny discussed below.

Business Segments

UnitedHealth Group reports results across four segments, aggregated under two brands. Based on full-year 2025 results:

UnitedHealthcare — the health benefits business, covering employer/individual plans, Medicare Advantage/Medicare Supplement, and Medicaid managed care, plus military and international coverage. Generated about $344.9 billion in revenue (roughly 77% of total company revenue) and $9.4 billion in operating earnings in 2025, serving about 49.8 million people.
Optum Health — direct patient care and care-delivery services (clinics, medical groups, ambulatory care, behavioral health), increasingly paid via value-based/capitated arrangements. Generated about $102.0 billion in revenue in 2025 but posted an operating loss of roughly $278 million, reflecting cost pressure from Medicare Advantage-linked value-based care arrangements.
Optum Insight — health care data, analytics, software, and revenue-cycle/administrative services sold to providers and payers (this segment includes what remains of Change Healthcare, acquired in 2022). Generated about $19.4 billion in revenue and $2.6 billion in operating earnings in 2025.
Optum Rx — the pharmacy benefit manager, plus mail-order/specialty pharmacy operations. Generated about $154.7 billion in revenue (roughly a third of company revenue) and $7.2 billion in operating earnings in 2025.

Combined, the three Optum units brought in about $270.6 billion in revenue and $9.5 billion in operating earnings for 2025 — meaning Optum and UnitedHealthcare contributed roughly comparable operating profit even though UnitedHealthcare's revenue is far larger, underscoring how much value Optum captures per dollar of revenue versus the lower-margin insurance business. For 2026, the company has guided to more than $439 billion in total revenue and more than $24 billion in operating earnings, with UnitedHealthcare targeted at $335 billion in revenue and Optum at $257.5 billion.

Competitors

Health insurance / managed care (UnitedHealthcare): Elevance Health (Anthem Blue Cross Blue Shield plans), CVS Health's Aetna, The Cigna Group, Humana (especially strong in Medicare Advantage), Centene and Molina Healthcare (Medicaid-focused), and the nonprofit Blue Cross Blue Shield network of independent plans.

Pharmacy benefit management (Optum Rx): CVS Health's Caremark and Cigna's Express Scripts form, together with Optum Rx, the "big three" PBMs that control the large majority of U.S. prescription volume. Smaller and newer entrants include Amazon Pharmacy and transparency-focused challengers such as Mark Cuban's Cost Plus Drugs.

Care delivery / provider services (Optum Health): CVS Health (via Oak Street Health and Aetna), Humana's CenterWell, hospital systems with employed physician groups, and other physician-aggregator platforms such as agilon health, ChenMed, and VillageMD (Walgreens-affiliated).

Health care IT, data and analytics (Optum Insight): Oracle Health (formerly Cerner), Epic Systems, and various revenue-cycle and analytics vendors serving hospitals and payers.

Indirect/adjacent competitors: hospital systems and integrated delivery networks that increasingly negotiate directly with employers, and government-run alternatives like traditional fee-for-service Medicare and state Medicaid programs, which compete for enrollment against UnitedHealthcare's Medicare Advantage and Medicaid managed-care plans.

Competitive Position

UnitedHealth Group is the clear scale leader in U.S. health care. According to a 2025 American Medical Association analysis, UnitedHealth holds about 16% of the national commercial health insurance market (ahead of Elevance and CVS/Aetna, each around 12%, and Cigna at 9%) and an even more dominant roughly 30% share of the Medicare Advantage market, well ahead of Humana (about 19%) and CVS/Aetna (about 12%); it holds the largest MA share in 44% of U.S. metro areas. That scale, combined with the UnitedHealthcare-Optum vertical integration model, gives the company real structural advantages: enormous negotiating leverage with hospitals, physicians, and drug manufacturers; a large captive population it can route toward its own Optum clinics and pharmacies; a data and analytics engine (built in part on the 2022 Change Healthcare acquisition) that few competitors can match; and diversified earnings that reduce dependence on any single line of business or government program.

That same integrated model, however, is now the company's biggest source of risk. The Department of Justice has been conducting an antitrust investigation into whether Optum's ownership of roughly 90,000 physicians (about a tenth of all U.S. doctors) allows UnitedHealthcare to steer members toward Optum-affiliated providers while disadvantaging rivals, and a related criminal inquiry has examined Medicare Advantage risk-adjustment (upcoding) and billing practices, along with newer scrutiny of Optum Rx's PBM practices. Politically, PBMs as an industry face bipartisan pressure over drug-pricing transparency and rebate practices, and Medicare Advantage plans broadly face tightening CMS reimbursement and stricter risk-adjustment audits — pressure that showed up directly in 2025 results, when medical cost trends (particularly in Medicare Advantage and Optum Health's value-based arrangements) ran hotter than the company had priced for, forcing guidance cuts, the abrupt May 2025 departure of CEO Andrew Witty (with former CEO Stephen Hemsley returning to the role), and a full-year outlook that assumes revenue will actually shrink slightly in 2026 as management repositions the business. The December 2024 killing of UnitedHealthcare CEO Brian Thompson also intensified public and political scrutiny of the industry's claims-denial and prior-authorization practices, adding reputational pressure on top of the regulatory and cost headwinds. Taken together, UNH remains the dominant player with unmatched scale and integration, but its next few years likely hinge on whether it can defend that integrated model against antitrust action while restoring the underwriting and cost discipline that let it consistently beat medical-cost expectations in the past.